Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 4726 AL 4740

Histamine H3 Receptor Antagonists for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials

Kubo M, Kishi T, Matsunaga S, Iwata N.

J Alzheimers Dis. 2015;48(3):667-71. doi: 10.3233/JAD-150393.

Vasculoprotection as a Convergent, Multi-Targeted Mechanism of Anti-AD Therapeutics and Interventions

Bhat NR.

J Alzheimers Dis. 2015;46(3):581-91. doi: 10.3233/JAD-150098.

APOE-ɛ4 Carrier Status and Donepezil Response in Patients with Alzheimer's Disease

Waring JF, Tang Q, Robieson WZ, King DP, Das U, Dubow J, Dutta S, Marek GJ, Gault LM.

J Alzheimers Dis. 2015;47(1):137-48. doi: 10.3233/JAD-142589.

Alzheimer's disease drug development based on Computer-Aided Drug Design

Zeng H, Wu X.

Eur J Med Chem. 2016 Oct 4;121:851-863. doi: 10.1016/j.ejmech.2015.08.039. Epub 2015 Sep 3.

Cerebral perfusional effects of 1-year rivastigmine treatment in Alzheimer disease: a case report

Ettorre E, Bersani FS, Colella F, Servello A, Minichino A, Megna V, Liberatore M, Biondi M, Marigliano V.

Riv Psichiatr. 2015 Jul-Aug;50(4):188-91. doi: 10.1708/2002.21650.

Caregiver burden in atypical dementias: comparing frontotemporal dementia, Creutzfeldt-Jakob disease, and Alzheimer's disease

Uflacker A, Edmondson MC, Onyike CU, Appleby BS.

Int Psychogeriatr. 2016 Feb;28(2):269-73. doi: 10.1017/S1041610215001647. Epub 2015 Oct 5.

[Molecular aspects of the pathogenesis and current approaches to pharmacological correction of Alzheimer's disease]

Kukharsky MS, Ovchinnikov RK, Bachurin SO.

Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(6):103-114. doi: 10.17116/jnevro20151156103-114.

Alzheimer's disease vaccine development: A new strategy focusing on immune modulation

Marciani DJ.

J Neuroimmunol. 2015 Oct 15;287:54-63. doi: 10.1016/j.jneuroim.2015.08.008. Epub 2015 Aug 9.

Can Chinese Herbal Medicine Adjunctive Therapy Improve Outcomes of Senile Vascular Dementia? Systematic Review with Meta-analysis of Clinical Trials

Zeng L, Zou Y, Kong L, Wang N, Wang Q, Wang L, Cao Y, Wang K, Chen Y, Mi S, Zhao W, Wu H, Cheng S, Xu W, Liang W.

Phytother Res. 2015 Dec;29(12):1843-57. doi: 10.1002/ptr.5481. Epub 2015 Oct 6.

Towards prevention and therapy of Alzheimer's disease

Pasinetti GM.

Mol Aspects Med. 2015 Jun-Oct;43-44:1-2. doi: 10.1016/j.mam.2015.09.001.

Myeloid cell-based therapies in neurological disorders: How far have we come?

Böttcher C, Priller J.

Biochim Biophys Acta. 2016 Mar;1862(3):323-8. doi: 10.1016/j.bbadis.2015.10.003. Epub 2015 Oct 8.

Possibility of Acetylcholinesterase Overexpression in Alzheimer Disease Patients after Therapy with Acetylcholinesterase Inhibitors

Kračmarová A, Drtinová L, Pohanka M.

Acta Medica (Hradec Kralove). 2015;58(2):37-42. doi: 10.14712/18059694.2015.91.

Nicotinic Cholinergic Mechanisms in Alzheimer's Disease

Shen J, Wu J.

Int Rev Neurobiol. 2015;124:275-92. doi: 10.1016/bs.irn.2015.08.002. Epub 2015 Sep 26.

Restoring calcium homeostasis to treat Alzheimer's disease: a future perspective

Popugaeva E, Vlasova OL, Bezprozvanny I.

Neurodegener Dis Manag. 2015 Oct;5(5):395-8. doi: 10.2217/nmt.15.36. Epub 2015 Oct 19.

Novel 1-Phenyl-3-hydroxy-4-pyridinone Derivatives as Multifunctional Agents for the Therapy of Alzheimer's Disease

Sheng R, Tang L, Jiang L, Hong L, Shi Y, Zhou N, Hu Y.

ACS Chem Neurosci. 2016 Jan 20;7(1):69-81. doi: 10.1021/acschemneuro.5b00224. Epub 2015 Oct 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias